Clinical diagnosis and staging of cholangiocarcinoma

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Nature Reviews Gastroenterology &Hepatology

• Publication date

  2011-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrgastro.2011.131PMID 21808282PMCID PMC3331791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prospective study of biliary cytology in suspected perihilar cholangiocarcinoma

  2011cited by this paper
• AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma

  2011cited by this paper
• Perihilar cholangiocarcinoma: A much needed but imperfect new staging system

  2011cited by this paper
• Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery

  2011cited by this paper
• Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma

  2011cited by this paper
• New staging system and a registry for perihilar cholangiocarcinoma

  2011cited by this paper
• Comparison of Serum Tumor Markers for Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma

  2010cited by this paper
• Imaging of cholangiolocellular carcinoma of the liver.

  2010cited by this paper
• DIAGNOSTIC AND THERAPEUTIC ADVANCES IN HEPATOLOGY Positron Emission Tomography Scan for a Hepatic Mass

  2010cited by this paper
• Distal Extrahepatic Cholangiocarcinoma Presenting as Cholangitis

  2010cited by this paper
• Univariate and Multivariate Analysis of Prognostic Factors in the Surgical Treatment of Hilar Cholangiocarcinoma

  2010cited by this paper
• Adequate Lymph Node Assessment for Extrahepatic Bile Duct Adenocarcinoma

  2010cited by this paper
• Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast‐enhanced ultrasound

  2010cited by this paper
• Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas

  2010cited by this paper
• Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma

  2009cited by this paper
• Comorbidity negatively influences prognosis in patients with extrahepatic cholangiocarcinoma.

  2009cited by this paper
• Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma.

  2009cited by this paper
• Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth

  2009cited by this paper
• The Prognosis and Survival Outcome of Intrahepatic Cholangiocarcinoma Following Surgical Resection: Association of Lymph Node Metastasis and Lymph Node Dissection with Survival

  2009cited by this paper
• The concept of perihilar cholangiocarcinoma is valid

  2009cited by this paper
• Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma.

  2009cited by this paper
• A conceptual proposal for staging ductal cholangiocarcinoma.

  2009cited by this paper
• Cholangiocarcinoma in cirrhosis: Absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma

  2009cited by this paper
• Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study

  2009cited by this paper
• Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas.

  2009cited by this paper
• Cholangiolocellular Carcinoma of the Liver: Imaging Findings

  2009cited by this paper
• Intrahepatic Cholangiocarcinoma: Prognostic Factors After Surgical Resection

  2009cited by this paper
• 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.

  2008cited by this paper
• Prognosis of Perihilar Cholangiocarcinoma: Hilar Bile Duct Cancer versus Intrahepatic Cholangiocarcinoma Involving the Hepatic Hilus

  2008cited by this paper
• Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.

  2008cited by this paper
• Staging cholangiocarcinoma by imaging studies.

  2008cited by this paper
• Intrahepatic Cholangiocarcinoma: Rising Frequency, Improved Survival, and Determinants of Outcome After Resection

  2008cited by this paper
• Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment

  2008cited by this paper
• A Proposed Staging System for Intrahepatic Cholangiocarcinoma

  2008cited by this paper
• MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings

  2008cited by this paper
• Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma

  2008cited by this paper
• Resection of Hilar Cholangiocarcinoma Concomitant Liver Resection Decreases Hepatic Recurrence

  2008cited by this paper
• Fluorescence in situ hybridization in diagnostic cytology.

  2007cited by this paper
• Pancreatic and Duodenal Invasion in Distal Bile Duct Cancer: Paradox in the Tumor Classification of the American Joint Committee on Cancer

  2007cited by this paper
• Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution

  2007cited by this paper
• An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas.

  2007cited by this paper
• Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin

  2007cited by this paper
• Surgical Outcomes of the Mass-Forming plus Periductal Infiltrating Types of Intrahepatic Cholangiocarcinoma: A Comparative Study with the Typical Mass-Forming Type of Intrahepatic Cholangiocarcinoma

  2007cited by this paper
• Case Report and Review of the Literature

  2007cited by this paper
• Pancreatoduodenectomy for Distal Cholangiocarcinoma: Prognostic Impact of Lymph Node Metastasis

  2007cited by this paper
• Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma

  2007cited by this paper
• Recurrence and Prognostic Factors of Ampullary Carcinoma after Radical Resection: Comparison with Distal Extrahepatic Cholangiocarcinoma

  2007cited by this paper
• High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma.

  2007cited by this paper
• Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria.

  2006cited by this paper
• Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.

  2006cited by this paper
• Staging of Klatskin tumours (hilar cholangiocarcinomas): comparison of MR cholangiography, MR imaging, and endoscopic retrograde cholangiography

  2006cited by this paper
• Predictors of Disease Recurrence Following Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma

  2006cited by this paper
• The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing Cholangitis

  2005cited by this paper
• Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins.

  2005cited by this paper
• Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.

  2005cited by this paper
• Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach.

  2005cited by this paper
• Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis

  2004cited by this paper
• Magnetic resonance imaging of cholangiocarcinoma

  2004cited by this paper
• Magnetic resonance imaging of cholangiocarcinoma.

  2004cited by this paper
• Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

  2003cited by this paper
• Lymphatic spread differs according to tumor location in extrahepatic bile duct cancer.

  2003cited by this paper
• Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer

  2003cited by this paper
• Cholangiocarcinoma: The Impact of Tumor Location and Treatment Strategy on Outcome

  2003cited by this paper
• Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.

  2002cited by this paper
• Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer.

  2002cited by this paper
• TNM: principles, history, and relation to other prognostic factors.

  2001cited by this paper
• Hepatic MR imaging using ferumoxides: prospective evaluation with surgical and intraoperative sonographic confirmation in 25 cases.

  2001cited by this paper
• A single center experience with extrahepatic cholangiocarcinomas.

  2001cited by this paper
• Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.

  2001cited by this paper
• A new staging system for mass‐forming intrahepatic cholangiocarcinoma

  2001cited by this paper
• Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes.

  2001cited by this paper
• Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma

  2001cited by this paper
• Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions.

  2001cited by this paper
• MR imaging of intrahepatic cholangiocarcinoma: use of ferumoxides for lesion localization and extension.

  2001cited by this paper
• Extraordinarily Elevated Ca19-9 in Benign Conditions: A Case Report and Review of the Literature

  2001cited by this paper
• Positron emission tomography with [18F]fluoro‐2‐deoxy‐D‐glucose for diagnosis and staging of bile duct cancer

  2001cited by this paper
• Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis.

  2000cited by this paper
• The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis

  2000cited by this paper
• Helical CT assessment in hilar cholangiocarcinoma: correlation with surgical and pathologic findings.

  1999cited by this paper
• Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management.

  1999cited by this paper
• Accurate preoperative evaluation of liver mass lesions without fine‐needle biopsy

  1999cited by this paper
• Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population.

  1999cited by this paper
• Gastroenterology and Hepatology: The Comprehensive Visual Reference

  1998cited by this paper
• Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment

  1998cited by this paper
• Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma.

  1998cited by this paper
• Drugs for the Gut: A Practical Guide to Gastrointestinal and Liver Therapy

  1998cited by this paper
• Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients.

  1997cited by this paper
• Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors.

  1997cited by this paper
• Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply

  1997cited by this paper
• The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.

  1996cited by this paper
• Hepatic lobar atrophy: association with ipsilateral portal vein obstruction.

  1996cited by this paper
• Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

  1996cited by this paper
• Cholangiocarcinoma: clinical significance of tumor location along the extrahepatic bile duct.

  1995cited by this paper
• Liver, biliary tract, and pancreas.

  1994cited by this paper
• Outcomes after curative resections of cholangiocarcinoma.

  1993cited by this paper
• Hilar Cholangiocarcinoma : An evaluation of subtypes with CT and angiography(共著)

  1992cited by this paper
• Hilar Cholangiocarcinoma

  1992cited by this paper
• Management strategies in resection for hilar cholangiocarcinoma.

  1992cited by this paper
• Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

  1975cited by this paper

• Circulating Tumor DNA in Cholangiocarcinoma: A Precision Oncology Roadmap

  2026cites this paper
• Radiofrequency Ablation (RFA) with Biliary Stenting in Malignant Biliary Obstruction: Case Series from a Single-Institution

  2026cites this paper
• Mechanisms of Cholangiocarcinoma, Molecular Subtypes, and Emerging Therapeutic Strategies

  2026cites this paper
• Anatomic subsets of cholangiocarcinoma: More different than alike.

  2026cites this paper
• Gut-liver axis drives the triple mechanism of liver inflammation-carcinogenesis: Microbial-immune-metabolic network.

  2026cites this paper
• The incidence and predictors of false-negative pancreatobiliary fluorescence in situ hybridization (PB-FISH) in biliary strictures: A prospective study

  2025cites this paper
• The diverse roles of circular RNAs in cholangiocarcinoma

  2025cites this paper
• Tumor de Klatskin: Breve revisión de la literatura y presentación de caso

  2025cites this paper
• Oral microbiota and biliary tract cancers: unveiling hidden mechanistic links

  2025cites this paper
• Current status and prospects of targeted therapy for cholangiocarcinoma based on molecular characteristics.

  2025cites this paper
• Oncolytic Properties of the Chimeric Poxvirus HOV-2 in Cholangiocarcinoma Models

  2025cites this paper
• LncRNA LUCAT1 as a prognostic biomarker in cholangiocarcinoma through targeting miR-141-3p: clinical and functional insights

  2025cites this paper
• Prognostic impact of RPL15 overexpression in intrahepatic cholangiocarcinoma: a marker of aggressive tumor behavior

  2025cites this paper
• Applications of 3D models in cholangiocarcinoma

  2025cites this paper
• LncRNA MIR17HG drives cisplatin resistance partially via miR-138-5p/AKAP9 axis in cholangiocarcinoma

  2025cites this paper
• Prognostic significance of the number of hepatic lesions in multifocal intrahepatic cholangiocarcinoma after radical resection: an IPTW propensity-score analysis

  2025influential citation
• The Integration of Multi-omics With Artificial Intelligence in Hepatology: A Comprehensive Review of Personalized Medicine, Biomarker Identification, and Drug Discovery.

  2025cites this paper
• VCP Promotes Cholangiocarcinoma Development by Mediating BAP1 Ubiquitination‐Dependent Degradation

  2025cites this paper
• High-sensitivity modified Glasgow prognostic score (HS-mGPS) is a prognostic biomarker for small duct-type intrahepatic cholangiocarcinoma—a retrospective cohort study

  2025cites this paper
• Integrated transcriptomics profile reveals the role of Gal-1 and miR-21 in intrahepatic cholangiocarcinoma progression.

  2025cites this paper
• Prognosis of cholangiocarcinoma patients based on multiple patterns of programmed cell death, integrated analysis of the immune microenvironment and drug sensitivity

  2025cites this paper
• Potential Influence of Antifungal-drug Resistant Pathogens in Patients with Cholangiocarcinoma and the Application of Nanoparticle Mechanisms as Novel Antifungal and Anticancer Agents

  2025cites this paper
• Immunotherapy in biliary tract cancer: effective but not enough?

  2025cites this paper
• Outcomes of Living-Donor Liver Transplantation for Cholangiocarcinoma Versus Hepatocellular Carcinoma in the United States

  2025cites this paper
• Intestinal microbiota in adults with cholangiocarcinoma identifies the dysregulated Blautia species and bile acid metabolic pathways

  2025cites this paper
• Advances in Endoscopic Diagnosis and Treatment of Hilar Cholangiocarcinoma

  2025cites this paper
• Chromosomal instability and genomic alterations in cholangiocarcinoma from Northeastern Thailand

  2025cites this paper
• The Prognostic Value of the XPC rs2228001 Single Nucleotide Polymorphism in Cholangiocarcinoma

  2025cites this paper
• The new era of cholangiocarcinoma treatment: application of nano-based drug delivery systems

  2025cites this paper
• Chinese multicenter expert consensus on the diagnosis and treatment of hilar cholangiocarcinoma: 2025 edition.

  2025cites this paper
• Hsa_circ_0000977 Sponges miR-338-3p to Drive Cholangiocarcinoma Progression and Predict Poor Prognosis.

  2025cites this paper
• Comprehensive review of Cholangiocarcinoma

  2025influential citation
• Interventional Radiology Posters Abstract

  2025cites this paper
• CT-based skeletal muscle loss predicts long term prognosis in patients with distal cholangiocarcinoma undergone pancreaticoduodenectomy

  2025cites this paper
• A proposed staging system for intrahepatic cholangiocarcinoma involving the hilar.

  2025cites this paper
• Targeting the ROCK2/UBA52/DRP1 axis enhances ferroptosis and overcomes pemigatinib resistance in Cholangiocarcinoma

  2025cites this paper
• Tumor cell-derived microparticles containing MTX (MTX-TMPs) in the treatment of cholangiocarcinoma by modulating MDSCs.

  2025cites this paper
• Single-cell analysis reveals that GFAP+ dedifferentiated Schwann cells promote tumor progress in PNI-positive distal cholangiocarcinoma via lactate/HMGB1 axis

  2025cites this paper
• Recent advances in the management of intrahepatic cholangiocarcinoma: the role of actionable mutations and targeted therapies

  2025influential citation
• Abdominal Bloating Following a Diagnosis of Aplastic Anemia: Correlation or Red Herring?

  2025cites this paper
• LiverSCA 2.0: An Enhanced Comprehensive Cell Atlas for Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

  2025cites this paper
• MicroRNAs in disease States.

  2025cites this paper
• Association of biliary microflora dysbiosis with cholangiocarcinoma: a single-center study

  2025cites this paper
• CHOLANGIOCARCINOMA: EPIDEMIOLOGY, HISTOPATHOLOGY, AND POTENTIAL PROGNOSTIC AND THERAPEUTIC IMPLICATIONS IN A COHORT FROM A REFERENCE CENTER IN SOUTHERN BRAZIL

  2025influential citation
• Hilar Bile Duct Granuloma Misdiagnosed As Hilar Cholangiocarcinoma: A Case Report

  2025cites this paper
• High cellular prion protein expression in cholangiocarcinoma: A marker for early postoperative recurrence and unfavorable prognosis

  2025cites this paper
• Challenges in the Diagnosis of Biliary Stricture and Cholangiocarcinoma and Perspectives on the Future Applications of Advanced Technologies

  2025cites this paper
• Detailed characterization and comparison of mouse models for cholangiocarcinoma.

  2025cites this paper
• Phase II study of transcatheter arterial chemoembolization (TACE) combined with apatinib for advanced perihilar cholangiocarcinoma

  2025cites this paper
• Efficacy and safety outcomes of PD-1/PD-L1 inhibitors in recurrent cholangiocarcinoma: a real-world, multicenter and retrospective study

  2025cites this paper
• Intrahepatic Cholangiocarcinoma Masquerading as Liver Abscess: A Case Report With Multimodal Imaging

  2025cites this paper
• Identifying risk factors of biliary tract cancers using a large Japanese regional insurance claims database

  2025cites this paper
• Delayed diagnosis of cholangiocarcinoma presenting with shoulder pain: A case report

  2024cites this paper
• PPM1G Inhibits Epithelial–Mesenchymal Transition in Cholangiocarcinoma by Catalyzing TET1 Dephosphorylation for Destabilization to Impair Its Targeted Demethylation of the CLDN3 Promoter

  2024cites this paper
• Predictive MINT Pathologic Risk Score for Adjuvant Chemotherapy in Resected Cholangiocarcinoma: A Propensity Score-Matched Multicenter Study in Thailand.

  2024cites this paper
• Long term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy.

  2024cites this paper
• Prognostic Significance of Albumin-Globulin Ratio in Urachal Carcinoma

  2024cites this paper
• High Expression of the Tumor Suppressor Protein ITIH5 in Cholangiocarcinomas Correlates with a Favorable Prognosis

  2024cites this paper
• Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort

  2024cites this paper
• The Expression and Clinicopathological Significance of BRAF V600E and Mucin 6 in Intrahepatic Cholangiocarcinoma: A Retrospective Study

  2024cites this paper
• Preoperative systemic inflammatory response index as a prognostic marker for distal cholangiocarcinoma after pancreatoduodenectomy

  2024cites this paper
• Machine Learning-based Macrophage Signature for Predicting Prognosis and Immunotherapy Benefits in Cholangiocarcinoma.

  2024cites this paper
• Same versus separate sessions of endoscopic ultrasound-guided fine-needle biopsy and endoscopic retrograde cholangiopancreatography for distal malignant biliary obstruction: a propensity score-matched study

  2024cites this paper
• Optimizing outcomes and personalizing care with targeted agents in advanced cholangiocarcinoma.

  2024cites this paper
• The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma.

  2024cites this paper
• Liver Oligometastasis in Biliary Tract Cancer and Impact on Survival Outcomes

  2024cites this paper
• CT Texture Analysis of Perihilar Cholangiocarcinoma—Associations With Tumor Grading, Tumor Markers and Clinical Outcome

  2024cites this paper
• Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome

  2024cites this paper
• A special case of intrahepatic cholangiocarcinoma misdiagnosed as hepatic cystic echinococcosis

  2024cites this paper
• Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF)

  2024cites this paper
• Diagnostic value of carbohydrate antigen 50 in biliary tract cancer: A large‐scale multicenter study

  2024cites this paper
• A Case of Extensive Cholangiocarcinoma Highlighting Challenges in Diagnosis and Treatment

  2024cites this paper
• Palliative Interventions in Advanced Cholangiocarcinoma

  2024cites this paper
• Interobserver variability in lymph node evaluation with endoscopic ultrasonography in cholangiocarcinoma

  2024cites this paper
• Intrahepatic cholangiocarcinoma with FGFR alterations: A series of Chinese cases with an emphasis on their clinicopathologic and genetic features.

  2024cites this paper
• Clinical significance of small extracellular vesicles in cholangiocarcinoma

  2024cites this paper
• Prognostic value of FGFR2 alterations in patients with iCCA undergoing surgery or systemic treatments: A meta‐analysis

  2024cites this paper
• Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinoma

  2024cites this paper
• Utility of methylated DNA markers for the diagnosis of malignant biliary strictures.

  2024cites this paper
• An Immunohistochemical Analysis of Osteopontin and S100 Calcium-binding Protein P is Useful for Subclassifying Large- and Small-duct Type Intrahepatic Cholangiocarcinomas

  2024cites this paper
• Efficacy and safety of maintenance therapy with anlotinib for advanced cholangiocarcinoma after first-line chemotherapy and the variations in efficacy based on different neutrophil-to-lymphocyte ratio (NLR)

  2024cites this paper
• The diagnostic performance of an [ 18 F]FDG PET/CT algorithm for preoperative evaluation of extrahepatic cholangiocarcinoma: a retrospective study

  2024cites this paper
• Advances in Endoscopic Ultrasound in Pancreatic Cancer Screening, Diagnosis, and Palliative Care

  2024cites this paper
• Predicting prognosis in intrahepatic cholangiocarcinoma by the histopathological features.

  2024cites this paper
• Surgical management, including the role of transplantation, for intrahepatic and peri-hilar cholangiocarcinoma.

  2024cites this paper
• Update on the Screening, Diagnosis, and Management of Cholangiocarcinoma.

  2024cites this paper
• Endoscopic light scattering spectroscopy for in vivo detection of pre-cancer in bile duct

  2024cites this paper
• Updates in Diagnosis and Endoscopic Management of Cholangiocarcinoma

  2024cites this paper
• Current advance in comprehensive management of hilar cholangiocarcinoma and navigation in surgery: non-systematic reviews.

  2024cites this paper
• Mechanistic insights into 125I seed implantation therapy for Cholangiocarcinoma: focus on ROS-Mediated apoptosis and the role of GPX2

  2024cites this paper
• New direction: identification of immunoinflammatory subtypes and potential therapeutic targets for cholangiocarcinoma

  2024cites this paper
• Durvalumab and T-DXd Synergistically Promote Apoptosis of Cholangiocarcinoma Cells by Downregulating EGR1 Expression Through Inhibiting P38 MAPK Pathway

  2024cites this paper
• Fibroblast growth factor therapies in biliary tract cancers: current and future state

  2024cites this paper
• The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma

  2024cites this paper
• Landscape of m6A RNA methylation regulators in liver cancer and its therapeutic implications

  2024cites this paper
• GOLPH3 promotes tumor malignancy via inhibition of ferroptosis by upregulating SLC7A11 in cholangiocarcinoma

  2024cites this paper
• CBX3 Downregulates HLTF to Activate PI3K/AKT Signaling Promoting Cholangiocarcinoma

  2024cites this paper
• Development of CAR-T Therapies and Personalized Vaccines for the Treatment of Cholangiocarcinoma: Current Progress, Mechanisms of Action, and Challenges.

  2024cites this paper
• Altered bile metabolome and its diagnostic potential for biliopancreatic malignancies.

  2024cites this paper
• The role of extracellular vesicles in cholangiocarcinoma tumor microenvironment

  2024cites this paper